These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16226079)

  • 61. Short QT syndrome: a predictable story.
    Brugada J; Gussak I; Brugada P
    Cardiology; 2014; 128(3):231-3. PubMed ID: 24818800
    [No Abstract]   [Full Text] [Related]  

  • 62. Inappropriate ICD discharge due to T-wave oversensing in a patient with short QT syndrome.
    Sun Y; Zhang P; Li X; Guo J
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):113-6. PubMed ID: 19793372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nifekalant enlarged the transmural activation-recovery interval difference as well as the peak-to-end interval on surface ECG in a patient with short-QT syndrome.
    Chinushi M; Sato A; Izumi D; Furushima H
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):877-80. PubMed ID: 22494577
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacotherapeutic Effects of Quinidine on Short QT Syndrome by Using Purkinje-Ventricle Model: A Simulation Study.
    Luo C; Whittaker DG; Liu T; Wang K; Li Y; He Y; Zhang H
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():2856-2859. PubMed ID: 31946488
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological and device approach to therapy of inherited cardiac diseases associated with cardiac arrhythmias and sudden death.
    Brugada J; Brugada R; Brugada P
    J Electrocardiol; 2000; 33 Suppl():41-7. PubMed ID: 11265735
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
    J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fetal cardiac repolarization abnormalities.
    Zhao H; Strasburger JF; Cuneo BF; Wakai RT
    Am J Cardiol; 2006 Aug; 98(4):491-6. PubMed ID: 16893703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome.
    Tanel RE; Triedman JK; Walsh EP; Epstein MR; DeLucca JM; Mayer JE; Fishberger SB; Saul JP
    J Cardiovasc Electrophysiol; 1997 Jul; 8(7):812-7. PubMed ID: 9255689
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome.
    Hancox JC; Du CY; Butler A; Zhang Y; Dempsey CE; Harmer SC; Zhang H
    Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220165. PubMed ID: 37122211
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Congenital long and short QT syndromes.
    Brenyo AJ; Huang DT; Aktas MK
    Cardiology; 2012; 122(4):237-47. PubMed ID: 22906875
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of hyperkalaemia on cardiac rhythm devices.
    Barold SS; Herweg B
    Europace; 2014 Apr; 16(4):467-76. PubMed ID: 24465006
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autonomic tone attenuates drug-induced QT prolongation.
    Smith AH; Norris KJ; Roden DM; Kannankeril PJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):960-4. PubMed ID: 17666066
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome.
    Hu D; Li Y; Zhang J; Pfeiffer R; Gollob MH; Healey J; Harrell DT; Makita N; Abe H; Sun Y; Guo J; Zhang L; Yan G; Mah D; Walsh EP; Leopold HB; Giustetto C; Gaita F; Zienciuk-Krajka A; Mazzanti A; Priori SG; Antzelevitch C; Barajas-Martinez H
    JACC Clin Electrophysiol; 2017 Jul; 3(7):727-743. PubMed ID: 29759541
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Rapid genetic testing facilitating the diagnosis of short QT syndrome.
    Redpath CJ; Green MS; Birnie DH; Gollob MH
    Can J Cardiol; 2009 Apr; 25(4):e133-5. PubMed ID: 19340359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.